170 related articles for article (PubMed ID: 17941284)
1. Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old.
Milgrom H; Kittner B; Lanier R; Hampel FC
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):358-63. PubMed ID: 17941284
[TBL] [Abstract][Full Text] [Related]
2. Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis.
Hampel FC; Kittner B; van Bavel JH
Ann Allergy Asthma Immunol; 2007 Dec; 99(6):549-54. PubMed ID: 18219837
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E
Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
[TBL] [Abstract][Full Text] [Related]
4. Safety of fexofenadine in children treated for seasonal allergic rhinitis.
Graft DF; Bernstein DI; Goldsobel A; Meltzer EO; Portnoy J; Long J
Ann Allergy Asthma Immunol; 2001 Jul; 87(1):22-6. PubMed ID: 11476456
[TBL] [Abstract][Full Text] [Related]
5. Onset of action of fexofenadine hydrochloride 60 mg/pseudoephedrine hydrochloride 120 mg in subjects aged 12 years with moderate to severe seasonal allergic rhinitis: a pooled analysis of two single-dose, randomized, double-blind, placebo-controlled allergen exposure unit studies.
Berkowitz RB; McCafferty F; Lutz C; Bazelmans D; Godfrey P; Meeves S; Liao Y; Georges G
Clin Ther; 2006 Oct; 28(10):1658-69. PubMed ID: 17157121
[TBL] [Abstract][Full Text] [Related]
6. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis.
Meltzer EO; Casale TB; Nathan RA; Thompson AK
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):311-7. PubMed ID: 10541423
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, safety and tolerability of an oral suspension of fexofenadine for children with allergic rhinitis.
Segall N; Grubbe RE; Levy AL; Maloney MJ; Nayak AS; Kittner B; Quesada JT
Allergy Asthma Proc; 2008; 29(4):380-5. PubMed ID: 18702885
[TBL] [Abstract][Full Text] [Related]
8. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis.
Hampel F; Ratner P; Mansfield L; Meeves S; Liao Y; Georges G
Ann Allergy Asthma Immunol; 2003 Oct; 91(4):354-61. PubMed ID: 14582814
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
LaForce CF; Corren J; Wheeler WJ; Berger WE;
Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders.
Prenner BM; Capano D; Harris AG
Clin Ther; 2000 Jun; 22(6):760-9. PubMed ID: 10929922
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis.
Bernstein DI; Schoenwetter WF; Nathan RA; Storms W; Ahlbrandt R; Mason J
Ann Allergy Asthma Immunol; 1997 Nov; 79(5):443-8. PubMed ID: 9396979
[TBL] [Abstract][Full Text] [Related]
13. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
Shah SR; Nayak A; Ratner P; Roland P; Michael Wall G
Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
[TBL] [Abstract][Full Text] [Related]
14. Brompheniramine, terfenadine, and placebo in allergic rhinitis.
Klein GL; Littlejohn T; Lockhart EA; Furey SA
Ann Allergy Asthma Immunol; 1996 Nov; 77(5):365-70. PubMed ID: 8933774
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of fexofenadine and cetirizine in the treatment of allergic rhinitis].
López García A; Paz Martínez D; Orea Solano M; Hernández Valencia G; Ramírez García A; Ramírez Ojeda H; Sánchez Medal LF; Soda Mehry A; Velarde Domínguez T; Betancourt Suárez MA; Méndez Vera JL
Rev Alerg Mex; 2001; 48(6):168-72. PubMed ID: 11802289
[TBL] [Abstract][Full Text] [Related]
16. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.
Nelson HS; Reynolds R; Mason J
Ann Allergy Asthma Immunol; 2000 May; 84(5):517-22. PubMed ID: 10831005
[TBL] [Abstract][Full Text] [Related]
17. Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis.
Wahn U; Meltzer EO; Finn AF; Kowalski ML; Decosta P; Hedlin G; Scheinmann P; Bachert C; Rosado Pinto JE; Baena-Cagnani C; Potter P; Simons FE; Ruuth E
J Allergy Clin Immunol; 2003 Apr; 111(4):763-9. PubMed ID: 12704355
[TBL] [Abstract][Full Text] [Related]
18. A non-comparative trial of the efficacy and safety of fexofenadine for treatment of perennial allergic rhinitis.
Bunnag C; Jareoncharsri P; Tunsuriyawong P; Pumhirun P; Limprasertsiri S; Chochaipanichnon L; Supiyaphun P; Kongpatanakul S
Asian Pac J Allergy Immunol; 2000 Sep; 18(3):127-33. PubMed ID: 11270466
[TBL] [Abstract][Full Text] [Related]
19. Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study.
Kaplan AP; Spector SL; Meeves S; Liao Y; Varghese ST; Georges G
Ann Allergy Asthma Immunol; 2005 Jun; 94(6):662-9. PubMed ID: 15984599
[TBL] [Abstract][Full Text] [Related]
20. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis.
Lee DK; Gray RD; Robb FM; Fujihara S; Lipworth BJ
Clin Exp Allergy; 2004 Apr; 34(4):646-9. PubMed ID: 15080820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
